The Clarke Inquiry Report, published on 2 April 2008, made 64 recommendations to the RPSGB Council, setting out the shape, style and functions that the profession wished to see in its new professional body.
Recommendation LIX of the Clarke Report suggested that "the RPSGB should convene a transitional committee charged with overseeing the project of preparing for the new professional body" with the main objective of this Committee being to produce "a prospectus for the new professional body so that potential members can make an informed choice about membership."
The RPSGB acted on this recommendation and asked Nigel Clarke to chair what has become known as TransCom, to produce the prospectus.
The prospectus developed by TransCom, The New Professional Body for Pharmacy - the Prospectus, was published on 28 November 2008, and is available on the TransCom website in English and Welsh language versions (click here).
Comments on the prospectus can be sent to TransCom until 9 January 2009, by using either the freepost form at the back of the prospectus or the feedback facility on the TransCom website (click here).
For press releases about the prospectus, click on the links below:
For more information, including full details of committee and meeting papers, see the TransCom website (click here).
In June 2007 the Royal Pharmaceutical Society of Great Britain undertook to commission an independent inquiry into the possible options for a new professional leadership body for pharmacy.
Consultation paper and report The inquiry, chaired by Nigel Clarke, published its consultation paper on 1 November 2007, and its report on 2 April 2008.
For the Clarke Inquiry consultation paper and report, click here
RPSGB response For the Society's response to the Clarke Inquiry Report, click here
RPSGB plans: summary In May 2008, the Royal Pharmaceutical Society of Great Britain published plans for a consultation with members, involvement of other organisations, and a timeline for the creation of a new professional body. For a summary of the plans, click on the link below:
RPSGB submission The Royal Pharmaceutical Society of Great Britain submitted its evidence to the inquiry on 25 January 2008. For the RPSGB full submission paper, a summary of the submission, and press release, click on the links below: